In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1

Journal of Clinical Investigation

Volumn 102, Issue 11, 1998, Pages 2002-2010

  Guedez, Liliana ^a   Stetler Stevenson, William G ^b   Wolff, Linda ^c   Wang, Jiun ^a   Fukushima, Paula ^a   Mansoor, Adnan ^a   Stetler Stevenson, Maryalice ^a,d  

^a Flow Cytometry Unit   (United States)

^b Division of Clinical Sciences   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Laboratory of Pathology   (United States)

Author keywords

Bcl 2; Bcl X; Burkitt's lymphoma; Extracellular matrix; Metalloproteinases

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ALKYLATION; ANGIOGENESIS; ARTICLE; B LYMPHOCYTE ACTIVATION; BURKITT LYMPHOMA; CELL DEATH; CELL SURVIVAL; DNA CONTENT; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION;

EID: 0032407788     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2881     Document Type: Article

References (9)

1. McDonnell, T.J., and S.J. Korsmeyer. 1991. Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14; 18). Nature. 349:254-256.
2. Cohen, J.J. 1991. Programmed cell death in the immune system. Adv. Immunol. 50:55-63.
3. Alexander, CM., E.W. Howard, M.J. Bissell, and Z. Werb. 1996. Rescue of mammary epithelial cell apoptosis and entactin degradation by tissue inhibitor of metalloproteinase-transgene. J. Cell Biol. 135:1669-1677.
4. Boudreau, N., C.J. Sympson, Z. Werb, and M. Bissell. 1995. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 267:891-893.
5. McGechan, G.M., J.D. Becherer, R.C. Bast, B. Champion, K.M. Connolly, J.G. Conway, F. Furdon, S. Karp, S. Kidao, A.B. McElroy, et al. 1994. Regulation of tumor necrosis-factor alpha processing by metalloproteinase inhibitor. Nature. 370:558-561.
6. Tanaka, M., T. Suda, K. Haze, N. Nakamura, N. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, et al. 1996. Fas ligand in human serum. Nat. Med. 2:317-322.
7. Stetler-Stevenson, M., A. Mansoor, M.S. Lim, P. Fukushima, J. Kehrl, G. Marti, K. Ptaszynski, J. Wang, and W.G. Stetler-Stevenson. 1997. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases (TIMPs) in reactive and neoplastic lymph nodes. Blood. 89:1708-1715.
8. Kossakowska, E.E., S.J. Urbanski, and D.E. Edwards. 1991. Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas. Blood. 77:2474-2481.
9. Mimori, K., M. Mori, T. Shiraishi, T. Fujie, K. Baba, M. Haraguchi, R. Abe, H. Ueo, and T. Akiyoshi. 1997. Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br. J. Cancer. 76:531-536.